|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hongo M, Nagasaki Y and Shoji T:
Epidemiology of esophageal cancer: Orient to Occident. Effects of
chronology, geography and ethnicity. J Gastroenterol Hepatol.
24:729–735. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gebski V, Burmeister B, Smithers BM, Foo
K, Zalcberg J and Simes J: Australasian Gastro-Intestinal Trials
Group: Survival benefits from neoadjuvant chemoradiotherapy or
chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet
Oncol. 8:226–234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: MAGIC Trial Participants: Perioperative
chemotherapy versus surgery alone for resectable gastroesophageal
cancer. N Engl J Med. 355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Hagen P, Hulshof MC, van Lanschot JJ,
Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al: CROSS Group:
Preoperative chemo-radiotherapy for esophageal or junctional
cancer. N Engl J Med. 366:2074–2084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohashi S, Miyamoto S, Kikuchi O, Goto T,
Amanuma Y and Muto M: Recent advances from basic and clinical
studies of esophageal squamous cell carcinoma. Gastroenterology.
149:1700–1715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Merkow RP, Bilimoria KY, McCarter MD, Chow
WB, Ko CY and Bentrem DJ: Use of multimodality neoadjuvant therapy
for esophageal cancer in the United States: Assessment of 987
hospitals. Ann Surg Oncol. 19:357–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu X, Xiao H, Zhao B, Zhang X and Wang G:
DNA repair gene ERCC1 C118T polymorphism predicts sensitivity of
recurrent esophageal cancerto radiochemotherapy in a Chinese
population. Thorac Cancer. 6:714–718. 2015. View Article : Google Scholar
|
|
9
|
Zhang Z, Zhang Q, Wu M, Li N and Heng Z:
Effects of 60 Co γ rays on radiosensitivity of down-regulated cell
strain hOGG1 expressed genes. Lin Chuang Fang She Yi Xue Shou Ce.
6:238–241. 2006.(In Chinese).
|
|
10
|
Horton JK, Watson M, Stefanick DF,
Shaughnessy DT, Taylor JA and Wilson SH: XRCC1 and DNA polymerase β
in cellular protection against cytotoxic DNA single-strand breaks.
Cell Res. 18:48–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Yao R, Fang S, Wang X and Li X:
Polymorphisms of ERCC1 and XRCC1 predict the overall survival of
advanced gastric cancerpatients receiving oxaliplatin-based
chemotherapy. Int J Clin Exp Med. 8:18375–18382. 2015.PubMed/NCBI
|
|
12
|
Li Q, Wu SG, Gao JM, Xu JJ, Hu LY and Xu
T: Impact of esophageal cancer staging on overall survival and
disease-free survival based on the 2010 AJCC classification by
lymph nodes. J Radiat Res. 54:307–314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sachsenheimer W, Piotrowski W and Bimmler
T: Quality of life in patients with intracranial tumors on the
basis of Karnofsky's performance status. J Neurooncol. 13:177–181.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kurokawa Y, Shibata T, Ando N, Seki S,
Mukaida H and Fukuda H: Which is the optimal response criteria for
evaluating preoperative treatment in esophagealcancer: RECIST or
histology? Ann Surg Oncol. 20:3009–3014. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu S, Zou S, Zhao J, Zhou B, Wan Z, Jia
H, Yuan K and He J: Association between polymorphism of XRCC1 gene
and susceptibility to esophageal carcinoma. Shi Yong Zhong Liu Za
Zhi. 28:253–260. 2013.(In Chinese).
|
|
16
|
Ayiheng Q and Bogela A: Study on laryngeal
cancer related on polymorphism of the Arg399Gln of XRCC1 DNA repair
gene in different nationalities in Xinjiang. Lin Chung Er Bi Yan
Hou Tou Jing Wai Ke Za Zhi. 27:948–951, 954. 2013.(In Chinese).
PubMed/NCBI
|
|
17
|
Kiyohara C, Takayama K and Nakanishi Y:
Association of genetic polymorphisms in the base excision repair
pathway with lung cancer risk: A meta-analysis. Lung Cancer.
54:267–283. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou Y and Che G: Analysis of the
relationship between DNA repair gene polymorphisms and lung cancer
susceptibility. J Environ Occup Med. 40:551–554. 2013.
|
|
19
|
Hoeijmakers JH: DNA damage, aging, and
cancer. N Engl J Med. 361:1475–1485. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ladiges WC: Mouse models of XRCC1 DNA
repair polymorphisms and cancer. Oncogene. 25:1612–1619. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Almeida KH and Sobol RW: A unified view of
base excision repair: Lesion-dependent protein complexes regulated
by post-translational modification. DNA Repair (Amst). 6:695–711.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Q, Zou BW, Xu Y, Xue JX, Meng MB, Liu
FJ, Deng L, Ma DY, Ao R and Lu Y: DNA repair gene polymorphisms and
clinical outcome of patients with primary small cell carcinoma of
the esophagus. Tumour Biol. 36:1539–1548. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou
G, Zhu Y, Miao X, Tan W and Wei Q: Identification of genetic
variants in base excision repair pathway and their associations
with risk of esophageal squamous cell carcinoma. Cancer Res.
64:4378–4384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sreeja L, Syamala VS, Syamala V, Hariharan
S, Raveendran PB, Vijayalekshmi RV, Madhavan J and Ankathil R:
Prognostic importance of DNA repair gene polymorphisms of XRCC1
Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J
Cancer Res Clin Oncol. 134:645–652. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang XR, Diehl S, Pfeiffer R, Chen CJ, Hsu
WL, Dosemeci M, Cheng YJ, Sun B, Goldstein AM and Hildesheim A:
Chinese and American Genetic Epidemiology of NPC Study Team:
Evaluation of risk factors for nasopharyngeal carcinoma in
high-risk nasopharyngeal carcinoma families in Taiwan. Cancer
Epidemiol Biomarkers Prev. 14:900–905. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang J, Zhang J, Zhao Y, Liao B, Liu J,
Li L, Liao M and Wang L: The Arg194Trp polymorphism in the XRCC1
gene and cancer risk in Chinese Mainland population: A
meta-analysis. Mol Biol Rep. 38:4565–4573. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu KS, Hou X, Shao G and Li Y:
Meta-analysis of X-ray repair cross complementing gene 1
polymorphisms and esophageal cancer risk. J Shantou Univ Med Col.
20:206–209, 212. 2007.
|
|
28
|
Liu S, Mu K, Zhang Z, Zeng M and Ge F: A
correlation study of the expression of XRCC1 and ERCC1 to the
effect of radiotherapy and prognosis in esophageal squamous cell
carcinoma. J Xinjiang Med Univ. 33:477–481. 2010.
|
|
29
|
Warnecke-Eberz U, Vallböhmer D, Alakus H,
Kütting F, Lurje G, Bollschweiler E, Wienand-Dorweiler A, Drebber
U, Hölscher AH and Metzger R: ERCC1 and XRCC1 gene polymorphisms
predict response to neoadjuvant radiochemotherapy in esophageal
cancer. J Gastrointest Surg. 13:1411–1421. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cornetta T, Festa F, Testa A and Cozzi R:
DNA damage repair and genetic polymorphisms: Assessment of
individual sensitivity and repair capacity. Int J Radiat Oncol Biol
Phys. 66:537–545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang X, Aheli H, Zhang Z, Lv Y and Ge F:
Association study on single nucleotide polymorphism in hOGG1,
XRCC1, XRCC3 and radiosensitivity in esophageal cancer. J Xinjiang
Med Univ. 33:473–476. 2010.
|
